Endo International Plc said it agreed to set aside $775 million to resolve the last batch of lawsuits alleging the company’s vaginal-mesh implants eroded in some women, leaving them incontinent and in pain.
Endo’s settlement of the remaining 22,000 mesh suits means the company has now set aside more than $2.6 billion to wipe out cases over the flawed medical devices, according to filings with the U.S. Securities and Exchange Commission.
